TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
ContributorsMolnar, Christoph; Scherer, Almut; Baraliakos, Xenofon; de Hooge, Manouk; Micheroli, Raphael; Exer, Pascale; Kissling, Rudolf O; Tamborrini, Giorgio; Wildi, Lukas M; Nissen, Michaël; Zufferey, Pascal; Bernhard, Jürg; Weber, Ulrich; Landewé, Robert B M; van der Heijde, Désirée; Ciurea, Adrian
Published inAnnals of the Rheumatic Diseases, vol. 77, no. 1, p. 63-69
Publication date2018
Abstract
Keywords
- Adult
- Axis, Cervical Vertebra/diagnostic imaging/pathology
- Cohort Studies
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Lumbar Vertebrae/diagnostic imaging/pathology
- Male
- Middle Aged
- Multivariate Analysis
- Radiography
- Severity of Illness Index
- Spine/diagnostic imaging/pathology
- Spondylitis, Ankylosing/diagnostic imaging/drug therapy/pathology
- Switzerland
- Treatment Outcome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
Affiliation
Citation (ISO format)
MOLNAR, Christoph et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. In: Annals of the Rheumatic Diseases, 2018, vol. 77, n° 1, p. 63–69. doi: 10.1136/annrheumdis-2017-211544
Main files (1)
Article (Published version)
Identifiers
- PID : unige:110919
- DOI : 10.1136/annrheumdis-2017-211544
- PMID : 28939631
ISSN of the journal0003-4967
